SCHEMBL29904440

SCHEMBL29904440

CC(C)n1nc(-c2ccc3cc(C(=O)O)[nH]c3c2)c2c(N)ncnc21

nearest known ligand 0.81

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 18/20 0.81
▸ RET P07949 10/20 0.81
▸ PIK3CD O00329 10/20 0.68
▸ ABL1 P00519 10/20 0.68
▸ SRC P12931 10/20 0.68
▸ PIK3CA P42336 10/20 0.68
▸ PIK3CB P42338 10/20 0.68
▸ PRKDC P78527 10/20 0.68
▸ PIK3CG P48736 9/20 0.68
▸ EGFR P00533 9/20 0.68
▸ HCK P08631 9/20 0.68
▸ MTOR P42345 9/20 0.68
▸ EPHB4 P54760 9/20 0.68
▸ PI4KB Q9UBF8 3/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20534730 1.00 KDR (0.81) KDRRETPIK3CDABL1SRC
SCHEMBL20535281 0.90 KDR (1.00) KDRRETPIK3CDABL1SRC
SCHEMBL20534669 0.86 RET (1.00) KDRRETPIK3CDABL1SRC
SCHEMBL20534933 0.86 KDR (1.00) KDRRETPIK3CDABL1SRC
SCHEMBL25858099 0.86 RET (0.86) KDRRETPIK3CDABL1SRC
SCHEMBL24907281 0.86 KDR (0.73) KDRRETPIK3CDABL1SRC
SCHEMBL29677750 0.85 RET (1.00) KDRRETPIK3CDABL1SRC
SCHEMBL21958123 0.85 RET (1.00) KDRRETPIK3CDABL1SRC
SCHEMBL29904436 0.84 RET (0.85) KDRRET
SCHEMBL20534665 0.84 RET (0.85) KDRRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115785100-B Compounds useful as RET inhibitors 癌症研究科技有限公司 2025-01-07 — — CN claimed
CN-115785100-B Compounds useful as RET inhibitors 癌症研究科技有限公司 2025-01-07 — — CN disclosed
CN-115785100-A Compounds useful as RET inhibitors 癌症研究科技有限公司 2023-03-14 — — CN disclosed
CN-110506043-B Compounds useful as RET inhibitors 癌症研究科技有限公司 2022-11-01 — — CN disclosed
Send feedback